{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:01:08Z","timestamp":1780290068133,"version":"3.54.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    American foulbrood (AFB), caused by the spore-forming bacterium\n                    <jats:italic>Paenibacillus larvae<\/jats:italic>\n                    , is the most destructive bacterial brood disease of\n                    <jats:italic>Apis mellifera<\/jats:italic>\n                    . Control is challenging because endospores persist for decades and antibiotic use is restricted by regulations, resistance, and residue concerns. Bacteriophages have re-emerged as a species-specific, residue-free strategy for AFB prevention and treatment. A PRISMA-guided systematic review was conducted searching PubMed, Embase, and Web of Science using the terms (bacteriophage OR phage) AND (honeybee OR\n                    <jats:italic>Apis mellifera<\/jats:italic>\n                    ). A total of 90 records were retrieved; after deduplication (19 removed), 71 titles and abstracts were screened. Eleven full texts were assessed for eligibility. Nine studies met inclusion criteria: three in adult bees or colonies, four in larvae, and two\n                    <jats:italic>in vitro<\/jats:italic>\n                    . Across studies, 27\n                    <jats:italic>P. larvae<\/jats:italic>\n                    phages were characterized\n                    <jats:italic>in vitro<\/jats:italic>\n                    , 18 tested in larval assays, and nine evaluated at the hive level, mainly via oral delivery. In a controlled hive trial, a three-phage cocktail provided complete protection from natural AFB (100% protected vs. 80% infection in controls;\n                    <jats:italic>p<\/jats:italic>\n                    \u202f&amp;lt;\u202f0.05) and enabled full recovery within 2\u202fweeks, performing comparably to or better than prophylactic antibiotics. Larval studies generally showed significantly improved survival with prophylactic or therapeutic dosing, though efficacy varied by phage. A biodistribution study found limited indirect larval exposure after adult feeding (~32 PFU\/larva at 24\u202fh), indicating hive-mediated inactivation as a key translational barrier. One phage bound both vegetative cells and spores while retaining ~93%\n                    <jats:italic>in-vitro<\/jats:italic>\n                    infectivity. Overall, phage cocktails show strong proof-of-concept, with formulation, delivery, and rational cocktail design as key translational priorities.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2026.1816537","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:18:16Z","timestamp":1780287496000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bacteriophage therapy against American foulbrood in honey bees: a PRISMA-guided systematic review"],"prefix":"10.3389","volume":"17","author":[{"given":"Nike","family":"Walter","sequence":"first","affiliation":[{"name":"Department for Trauma Surgery, University Hospital Regensburg","place":["Regensburg, Germany"]},{"name":"VOROS Fund for Regenerative Innovation","place":["Vaduz, Liechtenstein"]},{"name":"Institute of Virology, Helmholtz Centre Munich - German Research Centre for Environmental Health","place":["Neuherberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron Teja","family":"Bolte","sequence":"additional","affiliation":[{"name":"VOROS Fund for Regenerative Innovation","place":["Vaduz, Liechtenstein"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadali Khan","family":"Mirzaei","sequence":"additional","affiliation":[{"name":"Institute of Virology, Helmholtz Centre Munich - German Research Centre for Environmental Health","place":["Neuherberg, Germany"]},{"name":"TUM School of Life Sciences, Central Institute of Infection Prevention (ZIP), Technical University of Munich","place":["Freising, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[{"name":"Institute of Virology, Helmholtz Centre Munich - German Research Centre for Environmental Health","place":["Neuherberg, Germany"]},{"name":"TUM School of Life Sciences, Central Institute of Infection Prevention (ZIP), Technical University of Munich","place":["Freising, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Rupp","sequence":"additional","affiliation":[{"name":"Institute of Virology, Helmholtz Centre Munich - German Research Centre for Environmental Health","place":["Neuherberg, Germany"]},{"name":"Department of Trauma, Hand and Reconstructive Surgery, University Hospital Giessen","place":["Giessen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.69980\/ajpr.v28i5.451","article-title":"Bacteriophage therapy as an alternative to antibiotics: a meta-analysis","volume":"28","author":"Aloufi","year":"2025","journal-title":"Am. J. Psychiatr. Rehabil."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1128\/AEM.00804-15","article-title":"Paenibacilluslarvae-directed bacteriophage HB10c2 and its application in American foulbrood-affected honey bee larvae","volume":"81","author":"Beims","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jip.2017.09.010","article-title":"Bacteriophages as an alternative to conventional antibiotic use for the prevention or treatment of Paenibacillus larvae in honeybee hives","volume":"150","author":"Brady","year":"2017","journal-title":"J. Invertebr. Pathol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"588035","DOI":"10.3389\/fmicb.2021.588035","article-title":"Phages bind to vegetative and spore forms of Paenibacillus larvae and to vegetative Brevibacillus laterosporus","volume":"12","author":"Brady","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"wrae214","DOI":"10.1093\/ismejo\/wrae214","article-title":"Trade-offs between receptor modification and fitness drive host-bacteriophage co-evolution leading to phage extinction or co-existence","volume":"18","author":"Chen","year":"2024","journal-title":"ISME J."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"107660","DOI":"10.1016\/j.ijantimicag.2025.107660","article-title":"Nanomedicine for phage therapy: encapsulation strategies for enhanced antimicrobial efficacy","volume":"67","author":"Dorta-Gorr\u00edn","year":"2026","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/jisesa\/iev051","article-title":"Phage therapy is effective in protecting honeybee larvae from American foulbrood disease","volume":"15","author":"Ghorbani-Nezami","year":"2015","journal-title":"J. Insect Sci."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.3389\/fmicb.2019.02537","article-title":"Constructing and characterizing bacteriophage libraries for phage therapy of human infections","volume":"10","author":"Gibson","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e956","DOI":"10.1016\/S2666-5247(22)00288-9","article-title":"Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis","volume":"3","author":"G\u00f3mez-Ochoa","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e0144224","DOI":"10.1128\/spectrum.01442-24","article-title":"Comparative evaluation of long-term preservation methods for morphologically distinct bacteriophages","volume":"13","author":"Huang","year":"2025","journal-title":"Microbiol. Spectrum"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"20172140","DOI":"10.1098\/rspb.2017.2140","article-title":"The worldwide importance of honey bees as pollinators in natural habitats","volume":"285","author":"Hung","year":"2018","journal-title":"Proc. R. Soc. B Biol. Sci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/v13071217","article-title":"Isolation and characterization of phages active against Paenibacillus larvae causing American foulbrood in honeybees in Poland","volume":"13","author":"Jo\u0144czyk-Matysiak","year":"2021","journal-title":"Viruses"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3389\/fmicb.2020.01913","article-title":"Phages in therapy and prophylaxis of American foulbrood \u2013 recent implications from practical applications","volume":"11","author":"Jo\u0144czyk-Matysiak","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"fuaf061","DOI":"10.1093\/femsre\/fuaf061","article-title":"Phage cocktails: state-of-the-art technologies and strategies for effective design","volume":"50","author":"Kaneko","year":"2026","journal-title":"FEMS Microbiol. Rev."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.20517\/mrr.2023.16","article-title":"Paenibacillus larvae and their phages; a community science approach to discovery and initial testing of prophylactic phage cocktails against American foulbrood in New Zealand","volume":"2","author":"Kok","year":"2023","journal-title":"Microbiome Res. Rep."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/vetsci10030180","article-title":"American foulbrood\u2014old and always new challenge","volume":"10","author":"Matovi\u0107","year":"2023","journal-title":"Vet. Sci."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1111\/1462-2920.12292","article-title":"Clustering, persistence and control of a pollinator brood disease: epidemiology of American foulbrood","volume":"16","author":"Mill","year":"2014","journal-title":"Environ. Microbiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/10406387231200178","article-title":"Oxytetracycline-resistant Paenibacillus larvae identified in commercial beekeeping operations in Saskatchewan using pooled honey sampling","volume":"35","author":"Obshta","year":"2023","journal-title":"J. Vet. Diagn. Invest."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/jvp.12659","article-title":"Poster section 14: immunopharmacology and biologics","volume":"41","year":"2018","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref21","volume-title":"Potential economic impact of European and American foulbrood on Alberta\u2019s beekeeping industry","year":"2020"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41598-018-36432-x","article-title":"Bacteriophage biodistribution and infectivity from honeybee to bee larvae using a T7 phage model","volume":"9","author":"Ribeiro","year":"2019","journal-title":"Sci. Rep."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.12688\/openreseurope.17664.2","article-title":"Antibiotics in honey: a comprehensive review on occurrence and analytical methodologies","volume":"4","author":"Rodrigues","year":"2024","journal-title":"Open Research Europe"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1080\/09603123.2023.2197285","article-title":"Evaluation of antibiotic residues in honey: a systematic review and meta-analysis","volume":"34","author":"Shoaei","year":"2024","journal-title":"Int. J. Environ. Health Res."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"001595","DOI":"10.1099\/mic.0.001595","article-title":"Bacteriophage resistance evolution in a honey bee pathogen","volume":"171","author":"Spencer","year":"2025","journal-title":"Microbiology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/pharmaceutics16030374","article-title":"Phage delivery strategies for biocontrolling human, animal, and plant bacterial infections: state of the art","volume":"16","author":"Vila","year":"2024","journal-title":"Pharmaceutics"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1672198","DOI":"10.3389\/fmicb.2025.1672198","article-title":"Phage therapy for intestinal infections: efficacy, challenges, and future directions in translational research","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Microbiol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e1122698","DOI":"10.1080\/21597081.2015.1122698","article-title":"Experimental bacteriophage treatment of honeybees (Apis mellifera) infected with Paenibacillus larvae, the causative agent of American foulbrood disease","volume":"6","author":"Yost","year":"2016","journal-title":"Bacteriophage"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.3390\/ph18111688","article-title":"Phage encapsulation and delivery technology: a strategy for treating drug-resistant pathogenic microorganisms","volume":"18","author":"Yue","year":"2025","journal-title":"Pharmaceuticals"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"8848","DOI":"10.1038\/s41598-022-12856-4","article-title":"Establishment of apiary-level risk of American foulbrood through the detection of Paenibacillus larvae spores in pooled, extracted honey in Saskatchewan","volume":"12","author":"Zabrodski","year":"2022","journal-title":"Sci. Rep."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/antibiotics14101040","article-title":"Phage therapy as a novel alternative to antibiotics through adaptive evolution and fitness trade-offs","volume":"14","author":"Zhang","year":"2025","journal-title":"Antibiotics"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1816537\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:18:17Z","timestamp":1780287497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1816537\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":31,"alternative-id":["10.3389\/fmicb.2026.1816537"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1816537","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"article-number":"1816537"}}